These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32220059)

  • 21. Component-resolved IgE profiles in Austrian patients with a convincing history of peanut allergy.
    Ackerbauer D; Bublin M; Radauer C; Varga EM; Hafner C; Ebner C; Szépfalusi Z; Fröschl R; Hoffmann-Sommergruber K; Eiwegger T; Breiteneder H
    Int Arch Allergy Immunol; 2015; 166(1):13-24. PubMed ID: 25765158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural clinical tolerance to peanut in African patients is caused by poor allergenic activity of peanut IgE.
    Wollmann E; Hamsten C; Sibanda E; Ochome M; Focke-Tejkl M; Asarnoj A; Önell A; Lilja G; Gallerano D; Lupinek C; Thalhamer T; Weiss R; Thalhamer J; Wickman M; Valenta R; van Hage M
    Allergy; 2015 Jun; 70(6):638-52. PubMed ID: 25683061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blockade of peanut allergy with a novel Ara h 2-Fcγ fusion protein in mice.
    Liu Y; Sun Y; Chang LJ; Li N; Li H; Yu Y; Bryce PJ; Grammer LC; Schleimer RP; Zhu D
    J Allergy Clin Immunol; 2013 Jan; 131(1):213-21.e1-5. PubMed ID: 23199607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral mucosa effectively protects against peanut allergy in mice.
    Yoshida Y; Iijima K; Matsunaga M; Masuda MY; Jheng MJ; Kobayashi T; Kita H
    J Allergy Clin Immunol; 2024 Oct; 154(4):1060-1068. PubMed ID: 38795733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concurrent blockade of platelet-activating factor and histamine prevents life-threatening peanut-induced anaphylactic reactions.
    Arias K; Baig M; Colangelo M; Chu D; Walker T; Goncharova S; Coyle A; Vadas P; Waserman S; Jordana M
    J Allergy Clin Immunol; 2009 Aug; 124(2):307-14, 314.e1-2. PubMed ID: 19409603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Mouse Model of Peanut Allergy Induced by Sensitization Through the Gastrointestinal Tract.
    Orgel K; Kulis M
    Methods Mol Biol; 2018; 1799():39-47. PubMed ID: 29956142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peanut oral immunotherapy modifies IgE and IgG4 responses to major peanut allergens.
    Vickery BP; Lin J; Kulis M; Fu Z; Steele PH; Jones SM; Scurlock AM; Gimenez G; Bardina L; Sampson HA; Burks AW
    J Allergy Clin Immunol; 2013 Jan; 131(1):128-34.e1-3. PubMed ID: 23199605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-dose oral immunotherapy for children with anaphylactic peanut allergy in Japan.
    Nagakura KI; Yanagida N; Sato S; Nishino M; Asaumi T; Ogura K; Ebisawa M
    Pediatr Allergy Immunol; 2018 Aug; 29(5):512-518. PubMed ID: 29603410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunologic and clinical responses to parenteral immunotherapy in peanut anaphylaxis--a study using IgE and IgG4 immunoblot monitoring.
    Bullock RJ; Barnett D; Howden ME
    Allergol Immunopathol (Madr); 2005; 33(5):250-6. PubMed ID: 16287543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Standardizing the skin tape stripping method for sensitization and using it to create a mouse model of peanut allergy.
    Nesovic LD; Gonzalez Cruz PE; Rychener N; Wilks LR; Gill HS
    Int J Pharm; 2024 Sep; 662():124479. PubMed ID: 39019298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Three peanut-allergic/sensitized phenotypes with gender difference.
    Just J; Elegbede CF; Deschildre A; Bousquet J; Moneret-Vautrin DA; Crepet A;
    Clin Exp Allergy; 2016 Dec; 46(12):1596-1604. PubMed ID: 27512923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A single oral sensitization to peanut without adjuvant leads to anaphylaxis in mice.
    Proust B; Astier C; Jacquenet S; Ogier V; Magueur E; Roitel O; Belcourt C; Morisset M; Moneret-Vautrin DA; Bihain BE; Kanny G
    Int Arch Allergy Immunol; 2008; 146(3):212-8. PubMed ID: 18268389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Airway exposure initiates peanut allergy by involving the IL-1 pathway and T follicular helper cells in mice.
    Dolence JJ; Kobayashi T; Iijima K; Krempski J; Drake LY; Dent AL; Kita H
    J Allergy Clin Immunol; 2018 Oct; 142(4):1144-1158.e8. PubMed ID: 29247716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune reactivities to peanut proteins, agglutinins, and oleosins.
    Vojdani A
    Altern Ther Health Med; 2015; 21 Suppl 1():73-9. PubMed ID: 25599188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of IgE antibodies to recombinant peanut allergens in patients with reported reactions to peanut.
    Movérare R; Ahlstedt S; Bengtsson U; Borres MP; van Hage M; Poorafshar M; Sjölander S; Akerström J; van Odijk J
    Int Arch Allergy Immunol; 2011; 156(3):282-90. PubMed ID: 21720173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicting reactivity threshold in children with anaphylaxis to peanut.
    Reier-Nilsen T; Michelsen MM; Lødrup Carlsen KC; Carlsen KH; Mowinckel P; Nygaard UC; Namork E; Borres MP; Håland G
    Clin Exp Allergy; 2018 Apr; 48(4):415-423. PubMed ID: 29284183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peanut sensitization during the first 5 yr of life is associated with elevated levels of peanut-specific IgG.
    Sverremark-Ekström E; Hultgren EH; Borres MP; Nilsson C
    Pediatr Allergy Immunol; 2012 May; 23(3):224-9. PubMed ID: 22509759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-resolution epitope mapping by AllerScan reveals relationships between IgE and IgG repertoires during peanut oral immunotherapy.
    Chen G; Shrock EL; Li MZ; Spergel JM; Nadeau KC; Pongracic JA; Umetsu DT; Rachid R; MacGinnitie AJ; Phipatanakul W; Schneider L; Oettgen HC; Elledge SJ
    Cell Rep Med; 2021 Oct; 2(10):100410. PubMed ID: 34755130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical efficacy and immune regulation with peanut oral immunotherapy.
    Jones SM; Pons L; Roberts JL; Scurlock AM; Perry TT; Kulis M; Shreffler WG; Steele P; Henry KA; Adair M; Francis JM; Durham S; Vickery BP; Zhong X; Burks AW
    J Allergy Clin Immunol; 2009 Aug; 124(2):292-300, 300.e1-97. PubMed ID: 19577283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modified oral food challenge used with sensitization biomarkers provides more real-life clinical thresholds for peanut allergy.
    Blumchen K; Beder A; Beschorner J; Ahrens F; Gruebl A; Hamelmann E; Hansen G; Heinzmann A; Nemat K; Niggemann B; Wahn U; Beyer K
    J Allergy Clin Immunol; 2014 Aug; 134(2):390-8. PubMed ID: 24831438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.